|Bid||76.54 x 1100|
|Ask||76.65 x 1200|
|Day's Range||73.70 - 76.70|
|52 Week Range||61.78 - 138.60|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||-41.92%|
|Beta (5Y Monthly)||1.20|
|Expense Ratio (net)||0.35%|
The (ticker: XBI), which tracks small- and mid-cap biotech stocks, fell 33.7% in the first half of the year, which ended on Thursday. The (IBB), which tracks larger biotech names, fell 22.8%. In a note out early Friday, analysts with Cowen biotechnology team noted that June represented the XBI’s first positive month since last August.
A bear market has left Bitcoin and the S&P 500 at levels last seen in late 2020. Neither is going out of business anytime soon. Plus, investment newsletter commentary on commodities’ surprising slump, markets and midterms, and falling earnings estimates.
The S&P 500 fell more than 20% below its all-time high on Monday.